RT Journal Article
SR Electronic
T1 Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda <em>et al</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006784
DO 10.1136/jitc-2023-006784
VO 11
IS 3
A1 Immisch, Lena
A1 Papafotiou, George
A1 Popp, Oliver
A1 Mertins, Philipp
A1 Blankenstein, Thomas
A1 Willimsky, Gerald
YR 2023
UL http://jitc.bmj.com/content/11/3/e006784.abstract